CytoCore, Inc.'s Chief Scientist, Gorodeski, Presents Research on P2X7 for Treatment of Cancer at Purine and Pyrimidine Symposium in Chicago

CHICAGO--(BUSINESS WIRE)--Today Dr. George Gorodeski, Chief Scientist at CytoCore (OTCBB: CYCR), will present new aspects of his pioneering research at the 12th International Symposium on Purine and Pyrimidine Metabolism in Man, held at the InterContinental Hotel in Chicago.

MORE ON THIS TOPIC